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Abstract
While most studies emphasize on certain aspects of Pathogen-Host Interactions (PHI), such as the
preferential attachment of bacteria or virus to its human receptor homolog, studies have attempted to
methodically classify interactions among pathogenic proteins and their host proteins. Here we have ana-
lyzed 182 pathogens from The Pathogen-Host Interaction Search Tool (PHISTO) [1] and could identify
the proteins/protein coding genes that act on both virus and bacteria. Importantly there were few pro-
teins viz. P53 (Tumor protein p53), NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in
B-cells 1), GBLP (Guanine nucleotide-binding protein subunit beta-2-like-1), TOX4 (TOX high mobility
group box family member 4), PDIA1 (Protein disulfide-isomerase precursor), MHY9 (Myosin 9), RAC1
(Ras-related C3 botulinum toxin substrate 1), CCAR2 (Cell cycle and apoptosis regulator protein 2)
and ILF3 (Interleukin enhancer binding factor 3) that were more susceptible to both bacterial and viral
pathogens. Identification of such important interacting proteins (IIPs) can elicit significant insights for
better understanding the molecular mechanisms of such pathogens that interact with the human host.
1 Introduction
Pathogen-Host Interactions (PHI) are interactions that take place between pathogens (e.g. virus, bacteria,
etc.) and their host (e.g. humans, plants). Pathogen-Host Interactions can be illustrated on a single-cell
level (individual encounters of pathogen and host), on a molecular level (e.g. pathogenic protein binds
to receptor on human cell), at the level of an organism (e.g. virus infects host), or on the population level
(pathogen infections affecting a human population). Interactions among host and pathogen protein networks
are called pathogen-host interactomes and investigating them may allow us to apprehend and be aware of
the functioning of the host immune system and these important interacting proteins (IIPs) present in the
host cell could be utilized as potential drug targets [2]. We have analyzed 3,905 interactions (edges) from
∗Indian Insitute of Information Technology, Allahabad {rs171@iiita.ac.in}
†Indian Insitute of Information Technology, Allahabad {sanjeev@iiita.ac.in}
1
ar
X
iv
:1
60
9.
03
33
7v
1 
 [q
-b
io.
M
N]
  1
2 S
ep
 20
16
182 pathogens consisting of 1,188 proteins (nodes) that interact with 668 human proteins (nodes) from The
Pathogen-Host Interaction Interaction Search Tool (PHISTO). The entries in PHISTO are curated and are
also supported by strong experimental evidence as well as literature references.
2 Materials and Methods
In graph theory and network analysis, we make use of several indicators of centrality to identify the most
important vertices within a graph [3], [4]. Herein, for our undirected graph Γ, such that Γp = (Vp, Ep), Vp
is the set of all nodes (proteins) of Hp (Human) and Pp (Pathogenic) and Ep is the set of corresponding
edges (interactions) wherein Ep ⊆ [Vp]2. After analyzing the graph, we could pick out all the important
interacting proteins (IIPs) in the human host that acted as hubs in the pathogen-host interactive graph
and subsequently vulnerable to the pathogenic proteins. The pathogenic proteins were then meticulously
short-listed and were linked to their respective pathogenic organisms/strains. We could list out 9 highly
interacting hubs present in the human host that were involved with 786 pathogenic proteins. Herein, we
have emphasized only on those human protein/ protein coding genes that were predominantly present in 5
or more viral pathogenic proteins and also subsequently present in 2 or more bacterial protein barring a few
ones viz. RAC1, CCAR2 and ILF3.
Table 1: Overview of PHI Networks
Parameters Number (#)
Total no. of pathogens 182
No. of human proteins (Hp) 668
No. of pathogen proteins (Pp) 1,188
Total no. of proteins (Hp) + (Pp) 1,856
Total no. of interactions 3,905
3 Results and Discussions
Network Analysis and Centrality Indices
3.1 Node Degree Distribution
Definition: The node degree distribution is an indicator of the number of nodes with a degree of k. The
node degree of a particular node n is the number of interacting edges linked to n, in undirected networks.
3.2 Topological Coefficient
Definition: Topological coefficient T (n) of a node n with kn neighbors is defined as the number of neighbors
shared between a pair of nodes, kn and km, divided by the number of neighbors of node kn:
T (n) =
avg(J(n,m))
kn
(1)
where the value of J(n,m) is the number of neighbors shared between the nodes n and m, plus one if
there is a direct link between n and m. It gives a relative measure of a node that shares it’s neighbors with
other nodes and is defined for all nodes m that share at least one neighbor with n.
The predominant proteins/ protein coding genes are described as follows:
The P53 (cellular tumor antigen or phosphoprotein 53) protein acts as a tumor suppressor protein in
various tumor forms and it’s main function is to induce growth arrest depending on the physiological cir-
cumstances [5]. Further, it also acts as a trans-activator involved cell-cycle regulation controlling a set of
genes required for regulation [6], [7].
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Figure 1: The Pathogen-Host Network depicting the interactions (edges) between human and pathogenic
proteins (nodes).
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Figure 2: Node Degree Distribution depicts the scale-free network topology of our pathogen-host network.
Figure 3: Topological Coefficient is used to estimate the tendency of the nodes to have shared neighbors in
the pathogen-host network.
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Table 2: Summary of Network Statistics of PHI Networks
Parameter Statistics
Connected Components 82
Network Diameter 17
Network Centralization 0.105
Shortest Paths 2,610,796 (75%)
Characteristic Path Length 5.096
Avg. number of Neighbors 3.357
Network Heterogeneity 3.231
Multi-edge node pairs 496
Table 3: Overview of Important Interacting proteins (IIPs)
Human Protein Uniprot ID Virus Bacteria
P53 P04637 35 5
NFKB1 P19838 6 4
GBLP P63244 17 3
TOX4 O94842 12 3
PDIA1 P07237 9 2
MYH9 P35579 6 3
RAC1 P63000 3 7
CCAR2 Q8N163 13 2
ILF3 Q12906 23 1
Table 4: Physiological significance of few Important Interacting Proteins (IIPs) and their Node Degree
Distribution
S.No. Protein Degree Biological Function and its significance
1 P53 193 Apoptotic process, Cell regulation, Cell cycle arrest, Chromatin assembly
2 NFKB1 180 Apoptotic process, Cell differentiation, Signal Transduction, Tumorigenesis
3 GBLP 40 Assembly of signaling molecules, Cell cycle regulation, Promotes apoptosis
4 TOX4 23 Cell cycle progression, Control of Chromatin structure
5 PDIA1 22 Structural modification of exofacial proteins, Rearrangement of disulfide bonds
6 MYH9 13 Cytokinesis, Cytosketetal reorganization, Focal contacts formation
7 RAC1 41 Cell regulation, Cell polarization and growth-factor induced formation
8 CCAR2 18 Cellular integrity, Maintenance of genomic stability, Transcriptional activity
9 ILF3 30 Cell regulation, Regulates gene transcription
Table 5: List of few Important Interacting Proteins (IIPs) and their Disease Associations
S.No. Associated Disease List of IIPs associated with disease Reference Database
1 Adenocarcinoma P53 / NFKB1 CTD Human, CLINVAR
2 Brain Ischemia P53 / NFKB1 CTD Human
3 Colonic Neoplasms P53 / NFKB1 CTD Human
4 Diabetes Mellitus P53 / NFKB1 / RAC1 CTD Human
5 Kidney Failure P53 / NFKB1 / MYH9 CTD Human
6 Liver Carcinoma P53 / RAC1 CTD Human
7 Liver Diseases P53 / NFKB1 CTD Human
8 Neoplastic Cell Transformation P53 / NFKB1 / RAC1 CTD Human
9 Schizophrenia P53 / NFKB1 CTD Human, GWASCAT
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As such, P53 has an important role in preserving stability of the genome by preventing the activity of
mutagens in the genome [8], [9].
The NFKB1 (NF-kappa-B) is a pleiotropic transcription factor involved in a number of signal trans-
duction events that are instigated by stimulus that are related to cellular growth, cellular differentiation,
inflammation, spread of tumorigenicity and ultimately cell death [10].
GBLP (Guanine nucleotide-binding protein subunit beta-2-like 1) plays a role in the process of cell growth
by prolonging the G0/G1 phase of the cell cycle [11] and is also involved in the conscription, assembly and/or
regulation of a variety of signaling molecules.
TOX4 (TOX high mobility group box family member 4) is a component of the PTW/PP1 phosphatase
complex. It is involved in the control of chromatin structure and in the progression of cell cycle during the
transition phase [12].
PDIA1 (Protein disulfide-isomerase) catalyzes the rearrangement of -S-S- bonds. The formation, break-
age and rearrangement of -S-S- bonds is catalyzed by PDIA1 and hence may therefore cause structural
modifications in exofacial proteins [13].
MYH9 (Myosin 9) appears to play a role in maintaining the cell shape and reorganization of the cytoskele-
ton, cytokinesis and other specialized functions and plays an important role in focal contacts formation [14].
Interestingly, RAC1 (Ras-related C3 botulinum toxin substrate 1) is a GTPase associated with the plasma
membrane and regulates the cellular responses by binding to a variety of effector proteins [15]. It was found
to be more preferential to the bacterial proteins than the viral ones.
Interestingly, there are few proteins viz. CCAR2 and ILF3 which have more susceptibility to bind to the
viral proteins than the bacterial ones.
CCAR2 (Cell cycle and apoptosis regulator protein 2) is a multiprotein complex that acts at the interface
between core mRNP particles and RNA polymerase II (RNAPII). It acts by inhibiting the deacetylase activity
of SIRT1 leading to increasing acetylation levels of p53/TP53 and p53-mediated apoptosis [16].
ILF3 (Interleukin enhancer-binding factor 3) may facilitate as a translation inhibitory protein which binds
to mRNAs and other coding sequences of acid beta-glucosidase (GCase), inhibits binding to polysomes [17]
at the initiation phase of GCase mRNA translation.
3.3 Association of IIPs with Disease Modules
Diseases are not caused by a single gene, but rather in an orchestrated consequence of some abnormality
that involves a cascade of interactions encompassing several cellular components (proteins/protein coding
genes). We can well conclude that disease associated proteins are not confined to local communities, but
rather significantly incoherent.
The result also suggest that while network analysis of such pathogen-host interactions can identify crucial
local communities that point out important functionally related modules of the identified protein/protein
coding genes, identification of a specific disease module can be regarded as a community detection problem.
A community can be defined as a locally dense sub-graph in a network. Hence, identifying such sub-graphs
can help us decode the distribution that a disease causes in particular.
4 Summary and Conclusions
We have identified the proteins/protein coding genes that were more susceptible to both bacterial and viral
proteins. These are well targeted and act as potential drug targets. We have also inferred some disease
associations of few proteins/ protein coding genes namely P53, MHY9, NKKB1 & RAC1, that acted as
hubs. The identified important interacting proteins (IIPs) also share common functionality viz. cellular
differentiation, cell regulation, cell cycle arrest to cellular apoptosis. Our analysis of the pathogen-host
interactions (PHIs) to identify the important interacting proteins (IIPs) that act on both bacterial and viral
proteins can be practically applied over to other infectious fungal pathogens and protein-protein interactive
networks (PPINs) as well.
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